Needles in haystacks: Identifying specific peptide antigens for T cells

Current Opinion in Immunology

Volumn 8, Issue 2, 1996, Pages 271-277

  Shastri, Nilabh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANTIGEN DETECTION; ANTIGEN PRESENTATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; T LYMPHOCYTE;

EID: 0029888847     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80067-7     Document Type: Article

References (56)

1. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992, 255:1261-1263.
2. d. Science 1992, 256:1817-1820.
3. Kageyama S, Tsomides TJ, Sykulev Y, Eisen HN: Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J Immunol 1995, 154:567-576. Quantitative measurements of the range of ligand concentrations required for T-cell activation.
4. + T-cell antigens with single T-cell assays, and the first demonstration that cryptic translation can yield peptides for presentation to T cells.
5. b molecule. Nature 1990, 348:213-216.
6. Rotzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensee H-G: Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990, 348:252-254.
7. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC: Identification of self peptides bound to purified HLA-B27. Nature 1991, 353:326-329.
8. Rudensky AY, Preston-Hurlburt P, Hong S-C, Barlow A, Janeway CAJR: Sequence analysis of peptides bound to MHC class II molecules. Nature 1991, 353:622-627.
9. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature 1992, 358:764-768.
10. + cytotoxic lymphocytes in association with a class I MHC protein. Cell 1992, 69:989-998.
11. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH: HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 1992, 255:1264-1266.
12. Henderson RA, Cox AL, Sakaguchi K, Appella E, Shabanowitz J, Hunt DF, Engelhard VH: Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc Natl Acad Sci USA 1993, 90:10275-10279.
13. Aldrich CJ, Decloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J: Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class 1b antigen. Cell 1994, 79:649-658.
14. + cytotoxic T lymphocytes. J Exp Med 1995, 181:363-368.
15. ••].
16. + T-cell-stimulating antigens by protein rather than peptide purification.
17. Boon T, Van Pel A, De Plaen E, Chomez P, Lurquin C, Szikora J-P, Sibille C, Mariame B, Van den Eynde B, Lethe B, Brichart V: Genes coding for T-cell-defined Turn transplantation antigens: point mutations, antigenic peptides, and subgenic expression. Cold Spring Harbor Symp 1989, 54:587-596.
18. Karttunen J, Sanderson S, Shastri N: Detection of rare antigen presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci USA 1992, 89:6020-6024.
19. Malnati MS, Marti M, Lavaute T, Jaraquemada D, Biddison W, Demars R, Long EO: Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 1992, 357:702-704.
20. Sanderson S, Frauwirth K, Shastri N: Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc Natl Acad Sci USA 1995, 92:7217-7221.
21. Pfeifer JD, Wick MJ, Russell DG, Normark SJ, Harding CV: Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes. J Immunol 1992, 149:2576-2584.
22. + T-cell-stimulating antigen using Fc-receptor-mediated uptake of recombinant antigens in macrophages.
23. b complex to T-cells. J Immunol 1993, 150:2724-2736.
24. Valitutti S, Muller S, Cella M, Radovan E, Lanzavecchia A: Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995, 375:148-151. Mechanism that could account for the extraordinary ability of T cells to detect rare ligands on APC surface are discussed.
25. Shastri N: Single T cell probes for antigen/MHC expression. Curr Opin Immunol 1995, 7:258-262. A discussion of how single T-cell activation assays can be used for detecting peptide-MHC ligands.
26. Karttunen J, Shastri N: Measurement of ligand induced activation in single viable T-cells using the lacZ reporter gene. Proc Natl Acad Sci USA 1991, 88:3972-3976.
27. Sanderson S, Shastri N: LacZ inducible peptide/MHC specific T-hybrids. Int Immunol 1994, 6:369-376.
28. + T-cell assays for screening antigen genes in macrophages.
29. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995, 375:685-688.
30. Matzinger P: Tolerance, danger and the extended family. Annu Rev Immunol 1995, 12:991-1045. Presents arguments as to why self-reactive T cells exist in the repertoire and how their response is regulated.
31. Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Buschenfelde K-H, Beach D: A p16-INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995, 269:1281-1284. Identification of a cell-cycle-related gene as a tumor-specific antigen by expression cloning.
32. •].
33. Wang W, Meadows LR, den Haan JMM, Sherman NE, Chen Y, Blokland E, Shananowitz J, Agulnik AI, Hendrickson RC, Bishop CE et al.: Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995, 269:1588-1590. Solution to a 40-year old mystery of the H-Y antigen: MHC present peptides of the male-specific SMCY gene product. Peptides were identified by expression cloning and by peptide purification.
34. + T-cell-stimulating antigen by peptide purification and sequencing.
35. + T-cell-stimulating antigens.
36. Restifo NP, BaikK I, Irvine KR, Yewdell JW, McCabe BJ, Anderson RW, Eisenlohr LC, Rosenberg SA, Bennink JR: Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol 1995, 154:4414-4422.
37. Zitvogel L, Mayordomo JI, Tjandrawan T, Deleo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation and T helper cell 1-associated cytokines. J Exp Med 1996, 183:87-97.
38. Srivastava PK, Udono H: Heat shock protein-peptide complexes in cancer immunotherapy. Curr Opin Immunol 1994, 6:728-732.
39. Suto R, Srivastava PK: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995, 269:1585-1588. Heat-shock protein gp96 serves as a carrier of antigenic peptides, explaining why immunization with gp96 isolated from tumor cells elicits tumor-specific immunity.
40. + T cells by B7-transfected melanoma cells. Science 1993, 259:368-370.
41. •].
42. •].
43. Coulie PG, Lehmann F, Lethe B, Herman J, Lurquin C, Andrawiss M, Boon T: A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 1995, 92:7976-7980. Unexpected sources of antigenic peptides that stimulate T-cells indicate that the antigen-processing mechanism pays close attention to what is translated within the cell.
44. Shastri N, Nguyen V, Gonzalez F: Major histocompatibility class I molecules can present cryptic translation products to T-cells. J Biol Chem 1995, 270:1088-1091. Identification of the set of non-ATG codons that allow cryptic translation and yield the rare T-cell stimulating peptide-MHC ligands.
45. + T cell-stimulating peptide expressed in melanoma tumors by purification and mass spectroscopy.
46. Skipper JCA, Hendrickson RC, Gulden PH, Brichard V, van Pel A, Chen Y, Shabanowitz J, Wolfel T, Slingluff CL, Boon T et al.: An HLA-A2 restricted tyrosinase antigen on melanoma cells results from post-translational modification and suggests a distinct antigen processing pathway for membrane proteins. J Exp Med 1996, 183:527-534.
47. d by cytolytic T cells. Cell 1989, 58:293-303.
48. Van der Bruggen P, Traversai C, Chomez P, Lurquinn C, De Plaen E, Van den Eynde B, Knuth A, Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991, 254:1643-1647.
49. Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992, 176:1453-1457.
50. + T-cell clone. Proc Natl Acad Sci USA 1993, 90:11272-11276.
51. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, Coulie P, Boon T: The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993, 178:489-495.
52. Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 1994, 369:67-71.
53. Coulie PG, Brichard V, Van Pel A, Wolfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP et al.: A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994, 180:35-42.
54. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA: Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994, 91:3515-3519.
55. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld J-C, Coulie P, Boon T, Van der Bruggen P: BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995, 2:167-176.
56. Robbins PF, El-Gamil M, Li YF, Topalian SL, Rivoltini L, Sakaguchi K, Appella E, Kawakami Y, Rosenberg SA: Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J Immunol 1995, 154:5944-5950.